The Effect and Safety of the Four Points Transversus Abdominis Plane Block
1 other identifier
interventional
30
1 country
1
Brief Summary
The anterior abdominal wall from below the xiphoid to infraumbilical area is dominated by the sensory nerves which originate from the anterior rami of the thoracolumbar spinal nerves from T6-L1. The branches nerves from T7-T12 are between aponeurosis internal oblique and transversus abdominal muscle. They can be approached with the ultrasound guidance at subcostal and lateral abdominal wall position. The bilateral transversus abdominis plane (TAP) block has been demonstrated effectiveness and safety in postoperative analgesia to the under abdominal surgery. However, the effect of one to the upper abdominal surgery is unclear. The four points TAP block has been described the first in 2010. The effect of the four points TAP block in postoperative analgesia to the upper abdominal surgery has been reported in recent years. Besides, the effect of thoracic paravertebral block (PVB) in postoperative analgesia to liver resection was also reported. The both techniques have been performing in some studies. The effect and safety of the both techniques have been reported. However, the evidence level is still weak. The investigators need to find a technique, which has effectiveness as well as safety to replace the epidural analgesia, which was confirmed that had many complications, in postoperative analgesia to the hepatectomy. The investigators hypothesized that the four points TAP block under the ultrasound guidance has more effectiveness than the thoracic paravertebral block in postoperative analgesia to the hepatectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 3, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedStudy Start
First participant enrolled
August 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2020
CompletedJanuary 12, 2021
January 1, 2021
17 days
July 3, 2018
January 11, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The consumption of sulfentanil (mean)
The consumption of sufentanil is total dose of sufentanil which the participant used during 24 hours. Sufentanil is intravenously infused with PCA, with single dose 1 mcg, limit dose 8 mcg per a hour, and lockout time 5 minutes.
24 hours
Secondary Outcomes (3)
The complications of technique (frequency)
24 hours
Side-effect of sulfentanil (frequency)
48 hours
Satisfaction (mean)
24 hours
Study Arms (2)
TAP group
EXPERIMENTALThe TAP block is performed under the ultrasound guidance at four points: at subcostal and lateral abdominal wall at right-side and left-side. Drug: ropivacaine 0.375% 40 ml (maximum dose \<= 3 mg/kg). Maintenance: ropivacaine 0.375% 8 ml/hour during 48 hours.
PVB group
EXPERIMENTALThe paravertebral block is performed under the ultrasound guidance at T7. Drug: ropivacaine 0.5% 20 ml (maximum dose \<= 3 mg/kg). Maintenance: ropivacaine 0.25% 8 ml/hour during 48 hours.
Interventions
The TAP group will be performed at four points at abdominis plane with ropivacaine 0.375%
The PVB group will be performed at paravertebral space T7 with ropivacaine 0.5%
Ropivacaine has been treated the both group
Sufentanil has been included in Arm/Group Descriptions
Eligibility Criteria
You may qualify if:
- Subjects has selective hepatectomy
- Subjects has had II-III of Anesthesiologists Society Americans
You may not qualify if:
- History of chronic pain
- History of tolerance opioids
- History of psychology disorder
- Allergic to ropivacaine or opioids
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Binh Huynh
Ho Chi Minh City, Ho Chi Minh, 70000, Vietnam
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Binh V Huynh, Mr
Nhan dan Gia Dinh Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Department of Anesthesiology
Study Record Dates
First Submitted
July 3, 2018
First Posted
July 26, 2018
Study Start
August 15, 2018
Primary Completion
September 1, 2018
Study Completion
July 30, 2020
Last Updated
January 12, 2021
Record last verified: 2021-01